SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-218561
Filing Date
2022-08-11
Accepted
2022-08-11 16:17:30
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d737309d10q.htm   iXBRL 10-Q 1300984
2 EX-31.1 d737309dex311.htm EX-31.1 6576
3 EX-31.2 d737309dex312.htm EX-31.2 6567
4 EX-32.1 d737309dex321.htm EX-32.1 3141
5 EX-32.2 d737309dex322.htm EX-32.2 3132
  Complete submission text file 0001193125-22-218561.txt   4518686

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vinc-20220630.xsd EX-101.SCH 29324
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vinc-20220630_cal.xml EX-101.CAL 28780
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vinc-20220630_def.xml EX-101.DEF 136700
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20220630_lab.xml EX-101.LAB 284629
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20220630_pre.xml EX-101.PRE 232765
53 EXTRACTED XBRL INSTANCE DOCUMENT d737309d10q_htm.xml XML 551572
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39244 | Film No.: 221156128
SIC: 2834 Pharmaceutical Preparations